SavedAdd your journal

Journals / Yeni Üroloji Dergisi / 2015 / Cilt: 10 - Sayı: 3

Retrospective analysis of transrectal ultrasonography guided prostate biopsy

Transrektal ultrasonografi eşliğinde yapılan prostat biyopsilerinin retrospektif analizi

Ekrem AKDENİZ
Mustafa Suat BOLAT
Necmettin ŞAHİNKAYA
Ömer ALICI
Pages
31–35
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Patients with elevated prostate spesific antigene and digital rectal examination findings should be considered as high risk group and should be followed closely in terms of prostate cancer and transrectal ultrasound guided prostate needle biopsy is safe and effective procedure for this group of patients who have extend from benign to malign conditions

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Transrectal ultrasound guided prostate needle biopsy has become standard procedure in prostate cancer diagnosis.
📊
Key Findings & Data:Transrectal ultrasound guided prostate needle biopsies for suspicious prostate cancer diagnosis were evaluated retrospectively.Results: Mean age of patients was 66.09±7.65, mean serum prostate spesific antigene value 46.69±410.72 ng/mL and digital rectal examination positivity was 175 27.2% .
💡
Conclusion & Impact:Conclusions: Patients with elevated prostate spesific antigene and digital rectal examination findings should be considered as high risk group and should be followed closely in terms of prostate cancer and transrectal ultrasound guided prostate needle biopsy is safe and effective procedure for this group of patients who have extend from benign to malign conditions
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Patoloji · Prostat · Prostat spesifik antijen

Abstract

Objective: Transrectal ultrasound guided prostate needle biopsy has become standard procedure in prostate cancer diagnosis. We aimed to investigate the efficacy of transrectal ultrasound guided prostate needle biopsy on prostatic diseases and review histopathological outcomes.Materials and Methods: Six hundred and forty-three patients were evaluated in our clinic. Transrectal ultrasound guided prostate needle biopsies for suspicious prostate cancer diagnosis were evaluated retrospectively.Results: Mean age of patients was 66.09±7.65, mean serum prostate spesific antigene value 46.69±410.72 ng/mL and digital rectal examination positivity was 175 27.2% . Of the biopsy results 313 48.7% were benign prostatic hypertrophy, 139 21.6% were carcinoma of the prostate, 114 17.8% were prostatitis, 51 7.9% were prostatic intraepithelial neoplasia and 26 4% were atypical small acinar proliferation of prostate, respectively. Mean serum prostate spesific antigene level in carcinoma of the prostate group was statistically significantly higher in other groups. Prostate cancer incidence was statistically significantly high in the older than 65 years group than younger than 65 years group. Conclusions: Patients with elevated prostate spesific antigene and digital rectal examination findings should be considered as high risk group and should be followed closely in terms of prostate cancer and transrectal ultrasound guided prostate needle biopsy is safe and effective procedure for this group of patients who have extend from benign to malign conditions

Özet

Amaç: Transrektal ultrason eşliğinde prostat iğne biyopsisi, prostat kanseri tanısında standart prosedür haline gelmiştir. Biz bu çalışmada prostat hastalıklarının tanısında transrektal iğne biyopsi yönteminin etkinliğini ve histopatolojik sonuçlarını araştırmayı amaçladık.Gereç ve Yöntem: Ocak 2011- Aralık 2014 tarihleri arasında kliniğimizde transrektal ultrason eşliğinde on kor prostat biyopsisi yapılan 643 olgunun yaşları, klinik özellikleri, prostat spesifik antijen PSA seviyeleri ve histopatolojik sonuçları hasta dosyalarından retrospektif olarak değerlendirilerek veriler analiz edilmiştir. Bulgular: Hastaların yaş ortalaması 66.09 ± 7.65 yıl olarak bulundu. Serum prostat spesifik antijen PSA değeri 46,69 ± 410,72 ng / ml idi. Parmakla rektal muayene pozitifliği 175 27.2% hastada mevcuttu. En sık patolojik tanı benign prostat hipertrofisi BPH 313 % 48.7 olarak bulundu. Prostat kanseri, prostatit, prostatik intraepitelyal neoplazi PİN ve atipik small asiner proliferasyon ASAP oranları sırasıyla 139 % 21.6 , 114 % 17.8 , 51 % 7.9 ve 26 % 4 olarak bulundu. Prostat kanseri grubunda ortalama serum PSA düzeyi diğer gruplara göre yüksek bulundu. Prostat kanseri insidansı 65 yaş üzeri hastalarda anlamlı derecede yüksek izlendi.Sonuç: Yüksek PSA seviyesi ve parmakla rektal muayene bulguları olan hastalar prostat kanseri açısından yüksek riskli grup olarak kabul edilmelidir. Transrektal ultrason eşliğinde prostat iğne biyopsisi prostat hastalıklarının malign benign ayrımı açısından güvenli ve etkili bir yöntemdir

🔖

Cite This Article

AKDENİZ, E., BOLAT, M. S., ŞAHİNKAYA, N., ALICI, Ö. (2015). Retrospective analysis of transrectal ultrasonography guided prostate biopsy. Yeni Üroloji Dergisi, Cilt: 10 - Sayı: 3, 31–35. https://ajindex.com/articles/337237

References (13)

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics 2015. CA Cancer J Clin 2015;65:5-29.
  2. Boyle P, Ferlay J. Cancer incidence and mortality in Europe 2004. Ann Oncol 2005;16:481-8.
  3. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006;175:1605-12. Astraldi A. Diagnosis of cancer of the prostate: biopsy by rectal route. Urol Cutaneous Rev 1937;41:421-422.
  4. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-4.
  5. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with cura- tive intent-update 2013. Eur Urol 2014;65:124-37. Josephine A. Clinicopathological study of prostatic biop- sies. J Clin Diagn Res 2014;8(9):04-6.
  6. Walsh AL, Considine SW, Thomas AZ, Lynch TH, Maneck- sha RP. Digital rectal examination in primary care is impor- tant for early detection of prostate cancer: a retrospective cohort analysis study. Br J Gen Pract 2014;64(629):783-7.
  7. Carvalhal GF, Smith DS, Mager DE, Ramos C, Catalona WJ. Digital rectal examination for detecting prostate can- cer at prostate specific antigen levels of 4 ng/mL or less. J Urol 1999;161:835-9.
  8. Okotie OT, Roehl KA, Han M, Loeb S, Gashti SN, Catalona WJ. Characteristics of prostate cancer detected by digital rectal examination only. Urology 2007;70:1117-20.
  9. Gosselaar C, Roobol MJ, Roemeling S, Schröder FH. The role of the digital rectal examination in subsequent screen- ing visits in the European randomized study of screen- ing for prostate cancer (ERSPC), Rotterdam. Eur Urol 2008;54:581-8.
  10. Duskova K, Vesely S. Prostate specific antigen. Current clinical application and future prospects. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015;159:18-26.
  11. Obort AS, Ajadi MB, Akinloye O. Prostate-specific anti- gen: any successor in sight? Rev Urol 2013;15:97-107.
  12. Teoh JY, Yuen SK, Tsu JH, Wong CK, Ho BS, Ng AT, et al. Prostate cancer detection upon transrectal ultrasound- guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chi- nese population? Asian J Androl 2015:17;248-252.
  13. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antig